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Abstract
It was investigated whether dietary polyunsaturated fatty acids (PUFA) could influence colonic injury, tissue DNA 
damage, cytokines and myeloperoxidase activity (MPO) and plasma corticosterone in DSS-induced colitis rats. Male 
weaning Wistar rats were fed for 47 days with an AIN-93 diet with control (C), fish (F) or a mixture of fish and soybean oil 
(SF). The colitis was induced from day 36 until day 42 by 3% DSS in drinking water. On day 48, blood samples were 
collected for corticosterone determination. The distal colon was excised for histological analysis and to quantify the 
cytokine (IL-4, IL-10 and INF-γ), MPO and DNA damage. The disease activity index (DAI) was recorded daily during colitis 
induction. The DAI, MPO, histological analyses showed decreases only in the SF group compared with the C group. IL-
10 was increased and DNA damage was reduced in the groups F and SF, and an inverse correlation between these 
variables was found. There were no differences in corticosterone, IFN-γ and IL-4 levels. Soybean and fish oil mixture may 
be effective in improving colonic injury and DNA damage, and it could be an important complementary therapy in UC 
to reduce the use of anti-inflammatory drugs and prevent colorectal cancer.
Introduction
Ulcerative colitis (UC) is an inflammatory bowel disease
(IBD) characterized by recurrent episodes of colonic
inflammation and tissue regeneration[1]. Although the
pathogenesis of UC has not been entirely elucidated, the
chronic relapsing inflammation has a multifactorial etiol-
ogy. UC can be caused by an exaggerated immune
response to the intestinal flora in the context of genetic
predisposition [2,3] that can be attributed, at least in part,
to an imbalance between effector T cells (Teff ) and regu-
latory T cells (Treg)[4].
In IBD, there is increased synthesis and release of pro-
inflammatory mediators, such as eicosanoids, platelet
activating factor, reactive oxygen species (ROS), nitrogen
metabolites, chemokines and mainly cytokines [5] that
have been associated with disease severity, activity and
remission [2].
Active episodes of UC are characterized by mucosal
injury, increased vascular permeability, infiltration of
neutrophilic polymorphonuclear, leukocytes, disruption
of extracellular matrix and epithelial cell damage where
the synthesis and release of ROS, triggered mainly by
neutrophils, can mediate cell and tissues injury [6].
Patients with IBD are at increased risk of developing
colorectal cancer, and the inflammation has been associ-
ated with neoplastic changes through production of pro-
inflammatory cytokines and ROS[7]. Both mediators
activate nuclear transcription factor-kB (NF-kB), induc-
ible nitric oxide synthesis, and cyclooxygenase-2-related
signaling pathways, which may retard or suppress apop-
tosis in intestinal epithelial cells and modulate angiogene-
sis [8]. ROS, the cellular consequences of oxidative stress,
may cause DNA oxidation, resulting in damage to all four
bases and the deoxy-ribose-molecule [9,10]. Chronic
inflammation in the colonic mucosa caused by increased
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DNA damage of the epithelial cells, triggering the appear-
ance of genetic mutations and initiating colorectal car-
cinogenesis [10,11].
Disturbances of fatty acid status may relate to meta-
bolic consequences of IBD [12], and nutrition and dietary
factors can modulate immune function. Dietary fatty
acids such as omega 3 (w-3) polyunsaturated fatty acids
(PUFA) can exert an anti-inflammatory effect reducing
pro-inflammatory cytokines production [4].
The main purpose of this study was to examine the
effect of diets enriched with fish oil, soybean oil and fish
plus soybean oil mixture on markers of colonic injury,
cytokines (IL-4, IL-10 and IFN), MPO activity, corticos-
terone levels and DNA damage in colon of rats with
experimental UC induced by dextran sulfate sodium
(DSS). Colitis induced by DSS is widely used due to the
advantages of simplicity, degree of lesion uniformity, and
leukocytes infiltration [13]. DSS is also an experimental
model for oxidative stress [11,14].
Materials and methods
Animals and diet treatments
Eighteen male Wistar rats (28-30 days) were obtained
from the Center for the Development of Experimental
Models in Medicine and Biology at the Federal University
of São Paulo. They were kept under controlled light con-
ditions (12:12 h light-dark cycle with lights on at 07:00
A.M.) and temperature conditions (24 ± 1°C) with free
access to food and water. The animals were separated into
three groups (n = 6 per group) and received, for 47 days,
one of three diets: control (C group), fish (F group) or
soybean-fish (SF group) diet. All of the experiments
reported were previously reviewed and approved by
Institutional Ethics Committee for Experimental
Research (n° 01588/07).
The diets were prepared according to the recommenda-
tions of the American Institute of Nutrition. The stan-
dard AIN-93 [15] G (8% fat until 2 month) and M (5% fat
after 2 month) diets contained the same amount of pro-
tein, carbohydrates and lipids. The only difference
between the diets was the source of lipids: 100% of soy-
bean oil (source of w-6 PUFA) in the C group, 100% of
fish oil (source of w-3 PUFA) in the F group and a mixture
of 50% of soybean oil and 50% of fish oil in the SF group.
We obtained soybean oil and fish oil from Brazilian pro-
ducers. The detailed compositions of the diets are pre-
sented in Table 1, and the fatty acid profile of each diet is
presented in Table 2.
Induction of colitis, samples collection and procedures
Colitis was induced in all animals from day 36 to day 42
with 3% DSS (wt/v, prepared daily, mol wt 5.000-Fluka
BioChemika) put in the drinking water.
Animal body weight, presence of gross blood in the
feces and stool consistency were recorded daily for each
rat from day 35 to day 47. These parameters were each
assigned a score according to the criteria proposed by
Cooper et al [16], which was used to calculate a daily
mean disease activity index (DAI). Food and water con-
sumption was also recorded daily during this period.
On day 47, the rats, which were food deprived for 24 h,
were anesthetized (1:1 xilazine-ketamine). Blood samples
were collected by decapitation for plasma corticosterone
determination (trisodium citrate, as anticoagulant). The
distal colon was immediately excised, rinsed with phos-
phate buffered saline (PBS), weighed, and its length was
measured under a constant load (2 g). The distal colon
was longitudinally opened and subsequently divided into
four segments: 2 cm to histological analysis (immediately
fixed in 10% formaldehyde), 0.5 cm to DNA damage
detection (maintained in a fixative solution described
below), 0.5 cm to myeloperoxidase (MPO) activity deter-
mination, 0.5 cm to fatty acids composition and 6.0 cm to
cytokines (IL-4, IL-10 and INF-g) measurements. All
samples were stored at -80°C, except the histological
analysis samples.
Histological analysis
A cross-section of the distal colon (2 cm) was fixed in
10% paraformaldehyde solution. Afterwards, it was cut
into small fragments, dehydrated through an ethanol
series (70%-100%), cleared in xylol and embedded in par-
affin. The fragments were sliced into 5 μm thick sections
and stained with hematoxylin-eosin. Histological evalua-
tion was done by a pathologist who was blinded to the
experimental groups, and it was based on the intensity of
mononuclear and polymorphonuclear infiltrates in the
lamina propria, crypt dilation, cellular destruction and
mucosal ulceration. Histopathological changes were
graded according to the degree of inflammation using the
following scale: absent (0), light (1), moderate (2) and
intense (3), and the numbers represented the inflamma-
tion score (IS). Results were expressed as mean values of
IS ± standard error of the mean (SEM) for each experi-
mental group.
Fatty acids composition of diets
For total lipid extraction, diets samples were homoge-
nized in chloroform and methanol (2:1 v/v) followed by
the addition of an aqueous solution of KCL [17]. The
chloroform layer was dried under N2, and the total
extract was converted into methyl esters of fatty acids
using BF3 methanol, according to the method suggested
by the American Oil Chemist's Society [18]. The methyl
esters were diluted in hexane and analyzed by gas chro-
matography using a CHROMPACK® chromatographer
(model CP 9001) with a flame ionization detector and a
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Silica 59 mm × 0.25 mm). The detector temperature was
280°C, and the injector temperature was 250°C. The ini-
tial temperature was 180°C for 2 minutes (min), pro-
grammed to increase 10°C per min up to 210°C and held
for 30 min. The carrier gas used was hydrogen at a flow
rate of 2.0 mL.min-1. The identification of the fatty acids
was done comparing the retention times of the sample
components with authentic standards of fatty acid esters
injected under the same conditions. Fatty acid composi-
tion, as a percent of total acid weight, was calculated
using area counts of the chromatogram.
Measurement of colon cytokine and plasma concentration
Tissue samples were homogenized in 3.5 mL PBS solu-
tion and centrifuged at 1200 rpm for 10 minutes. Super-
natants were transferred into clean Eppendorf tubes and
stored at -80 °C. The concentration of INF-γ, IL-4 and IL-
10 were measured by enzyme-linked immunosorbent
assay technique using commercially available kits pur-
chased from R&D Systems.
The plasma corticosterone concentration was quanti-
fied by the fluorimetric method [19].
Myeloperoxidase Activity in the Colon
Tissues colon samples (0.5 cm) obtained from the distal
colon were homogenized in 0.5% (w/v) hexadecyltrimeth-
ylammonium bromide in 50 mM potassium phosphate
buffer, pH 6.0. For the myeloperoxidase (MPO) assay, 50
μL of each sample were added to 200 μL of o-dianisidine
solution (0.167 mg/mL o-dianisidine dihydrochloride,
0.0005% hydrogen peroxide in 50 mM phosphate buffer,
pH 6.0) immediately prior to reading the change in absor-
bance at 460 nm over 5 minutes using a microplate reader
(Multiscan MS, Labsystems, Helsinki, Finland).
Comet Assay
The Comet assay detects DNA damage (strand breaks
and alkali-labile sites) at the individual cell level. Cells
from distal colon samples were isolated as described
below. The biopsies were pooled and incubated with 5.5
mg proteinase K (Sigma-Aldrich, St. Louis, MO, USA)
and 3 mg collagenase (Invitrogen Life Technologies,
Grand Island, NY, USA) in 3 mL of Hank's balanced salt
solution (HBSS; Invitrogen) for 45 min at 37°C to liberate
the cells; the cells were then re-suspended in 10 mL of
HBSS. The resulting suspensions were centrifuged at 750
g for 5 min, and the supernatant was discarded. Since
high leukocyte content could lead to a bias in the levels of
DNA damage from colon cells, leukocyte contamination
was assessed in the cell suspensions. Aliquots of 100 mL
were dropped onto a slide, fixed with acetone, and
stained with hematoxylin and eosin. The slides were ana-
lyzed by blinded examiners for leukocyte levels.
Cell Viability
The Comet assay should be performed only on samples
having a cell viability of more than 75%. Therefore, cell
viability was determined using the fluorescein-diacetate
(FDA)/ethidium bromide (EtBr; Sigma-Aldrich, St. Louis,
MO, USA) assay. Briefly, a fresh staining solution was
prepared containing 30 mL FDA in acetone (5 mg/mL),
200 mL EtBr in PBS (200 mg/mL), and 4.8 mL PBS (Invit-
rogen). The single cell suspension (25 mL) was then
Table 1: Composition of the experimental diets according AIN-9315
Diet (g/100 g)
Ingredient Control Fish Soybean/Fish
Casein+ 20.0 (14.0) 20.0 (14.0) 20.00 (14.0)
Corn starch* 62.0 (71.1) 62.0 (71.1) 62.00 (71.1)
Cellulose* 5.0 (5.0) 5.0 (5.0) 5.0 (5.0)
Mineral mix AIN-93@ 3.5 (3.5) 3.5 (3.5) 3.5 (3.5)
Vitamin mix AIN 93@ 1.0 (1.0) 1.0 (1.0) 1.0 (1.0)
Choline bitartrate* 0.25 (0.25) 0.25 (0.25) 0.25 (0.25)
L-cystina* 0.3 (0.18) 0.3 (0.18) 0.3 (0.18)
Butylhydroquinone* 0014 (0.007) 0.014 (0.007) 0.014 (0.007)
Fish oil# 0 8.0 (5.0) 4.0 (2.5)
Soybean oil& 8.0 (5.0) 0 4.0 (2.5)
The first number refers to the growth diet (AIN-93 G), and the number in parentheses refers to the maintenance diet (AIN-93 M). +casein was 
obtained from Sinth. *L-cystine, corn starch, butylhydroquinone, cellulose and choline bitartrate were obtained from Viafarma, Brazil. 
Soybean oil&from Lisa, Brazil and fish oil from Campestre, Brazil. Mineral mix@ and vitamin mix@ AIN-93 were supplied by Rhoster Ind. and 
Com. LTDA.
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slide and covered with a coverslip. Viable cells appeared
fluorescent-green, whereas red-stained nuclei indicated
dead cells. At least 200 cells were counted per sample.
Determination of DNA Damage
The alkaline Comet assay was performed on the single
cell suspensions, according to Singh et al.[20], but with
some modifications. Briefly, 15 mL of the single cell sus-
pension (~ 2 × 104 cells) were mixed with molten 0.5%
low-melting-point agarose (Promega Co. Madison, WI,
USA) and spread on agarose-precoated microscope
slides. The slides were immersed overnight at 4°C in
freshly prepared cold lysing solution (2.5 M NaCl, 100
mM EDTA, 10 mM Tris, 2% sodium salt N-Lauryl sar-
cosine, pH 10, with 1% Triton X-100 and 10% DMSO; all
from Sigma-Aldrich). Subsequently, the cells were
exposed to alkaline buffer (1 mM EDTA and 300 mM
NaOH, pH ~13.4) at 4°C for 40 min to allow DNA
unwinding and expression of alkali-labile sites. Electro-
phoresis was then conducted in the same solution at 4°C
for 20 min using 25 V and 300 mA. After incubation, the
slides were washed in cold PBS; lysis, denaturation and
electrophoresis were then performed in the same manner
as described above. After electrophoresis, the slides were
neutralized (0.4 M Tris, pH 7.5), stained with 40 mL EtBr
(20 mg/mL) and analyzed with a fluorescence microscope
(Eclipse E400; Nikon, Melville, NY, USA), using an image
analysis system (Komet 5.5; Kinetic Imaging, Notting-
ham, UK). Two hundred randomly selected cells (100
from each of two replicate slides) were evaluated from
each sample, and the mean of the Olive tail moment DNA
was determined. Tail moment (TM) is defined as the
product of DNA in the tail, and the mean distance of
migration in the tail is calculated by multiplying tail
intensity/sum comet intensity by the center of gravity of
the tail - peak position. A higher percentage of tail DNA
signifies a higher level of DNA damage.
Statistical analysis
Data were expressed as means ± standard error of the
mean (SEM). Statistical analysis was performed by one-
way analysis of variance (ANOVA) followed by the Bon-
ferroni's post hoc test for multiple comparisons. Signifi-
cance level was set at p < 0.05. To verify the correlation
between two variables, Pearson's correlation coefficients
(r) were used.
Results
Fatty acids composition of diets and food intake
Table 2 shows the fatty acid composition of diets. The
levels of monounsaturated fatty acids (MUFA) were not
different among the diets. The saturated fatty acid
Table 2: Fatty acids composition of the experimental diets
Percentage of total fatty acids
Fatty acids (%) Control Fish Soybean/Fish
14:0 0.6 8.9 2.3
16:0 10.2 20.8 12.9
18:0 3.2 5.5 3.9
16:1 (n-7) 1.6 8.4 4.3
18:1 (n-9) 20.5 9.8 15.2
18:2 (n-6) 49.4 4.8 35.6
18:3 (n-3) 4.9 0.8 2.4
20:4 (n-6) Nd Nd Nd
20:5 (n-3) Nd 16.2 8.2
22:6 (n-3) Nd 14.9 6.4
Ni 9.6 9.9 8.8
Total SAFA 14.0 35.2 19.1
Total MUFA 22.1 18.2 19.5
Total PUFA 54.3 36.7 52.6
w-6 PUFA 49.4 4.8 35.6
w-3 PUFA 4.9 31.9 17.0
w-6:w-3 PUFA 10:1 1:6 2:1
SAFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; Nd, not detected, Ni, Not identified.
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and SF groups. In the SF diet, in which fish oil was mixed
with soybean oil, there was no excess of SAFA like there
was in the Fish diet. In relation to PUFA, the F group had
a lower amount compared with the C and SF groups;
however, the main difference among the diets was the w-
6:w-3 PUFA ratio. The C group showed a w6:w3 ratio that
was similar to western diets (10:1) while the F group had a
ratio (1:6) with an excess of w-3 PUFA. In the SF group, a
balanced ratio (2:1) was observed.
No difference in food intake was observed among the
three groups (data no shown).
Body weight before and after colitis induction, disease 
activity index (DAI), colon length, inflammation score (IS) 
and corticosterone
Animals were monitored from weaning, and their weight
was evaluated once a week before induction and daily
after colitis induction. Up to day 36, there was no differ-
ence in weight among the groups; however, after colitis
induction, groups SF and F presented with body weight
increases compared with the C group (Table 3).
The induction of colitis resulted in significant changes
in body weight, stool consistence, fecal blood, food intake
and a worsened general status. The three groups pre-
sented a progressive DAI from the 3rd day with DSS (day
38) until the 7th day (day 42) (Figure 1). During colitis
induction, the F group tended to be similar to the SF
group in stool consistency and weight loss; however, rec-
tal bleeding was more intense (data not shown).
After stopping DSS (day 43), the clinical symptoms
showed a regression, normalizing in day 47. The animals
were sacrificed at day 48 (recuperation phase) without
any clinical symptoms (Figure 1), although the colon
damage remained as the histological examination graded
by a pathologist (Figure 2).
SF group presented a significantly decreased DAI on
days 41, 42 and 43 when compared with the C group. The
F group had an intermediate DAI, which was between
those for the C and SF groups (Figure 1).
Colon length, an inflammation indirect marker, was
higher in the SF and F groups in relation to the C group
(Table 4). In addition, IS revealed typical inflammatory
changes in the colonic architecture (ulceration, crypt
dilation, mixed cell infiltration and granulocytes) in all
groups, but only the SF group presented with lower tissue
damage when compared with C (Figure 2), probably asso-
ciated with a decreased incidence of diarrhea, blood in
feces and smaller weight loss in this group.
Regarding plasma corticosterone levels, there were no
differences among the groups.
Cytokines, MPO activity and DNA damage
MPO activity was significantly lower in the SF group than
in the C group, suggesting a reduced neutrophil infiltra-
tion in colon tissues, and again, the F group had an inter-
mediate result (Table 5). Interestingly, no difference was
observed in the IL-4 and INF-γ cytokine tissue concen-
trations. However, in relation to IL-10, an important
cytokine in maintaining gastrointestinal mucosal homeo-
stasis, increased values were found in the F and SF groups
when compared with the C group (Table 5).
The detected DNA damage levels in colon were signifi-
cantly lower in the SF and F groups (Table 5), suggesting
an inverse association between decreased DNA damage
and increased IL-10 levels. In fact, a linear correlation
test between these variables was performed and a strong
Table 3: Values indicate body weight (g) before and during induction of colitis by DSS
Before induction of colitis During induction of colitis
Days 7 14 21 28 35 42 47
Control 129.83 ± 3.13 167.49 ± 2.19 209.41 ± 3.50 244.96 ± 3.26 286.25 ± 2.58 265.82 ± 5.88 278.39 ± 7.81
Fish 140.70 ± 5.05 172.33 ± 5.29 224.53 ± 8.07 264.47 ± 10.74 301.98 ± 4.14 290.36 ± 9.04* 311.69 ± 5.84*
Soybean/Fish 129.57 ± 4.08 168.79 ± 3.84 210.01 ± 4.00 250.23 ± 4.57 289.88 ± 5.28 301.58 ± 2.06* 314.86 ± 6.60*
Values represent means ± SEM, n = 6 rats; * Different (p < 0.05) from Control group.
Figure 1 Time course of changes in the DAI (combined scores of 
weight loss, stool consistency and bleeding) in rats fed control, 
fish or soybean/fish diet, based on Cooper et al. criteria [16]. Val-
ues represent means ± SEM, n = 6 rats; * Different (p < 0.05) from Con-
trol group.
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DNA damage (r = 0.77) was found (Figure 3).
Discussion
The results showed that the colon inflammation induced
by DSS was significantly less severe in group SF, showing
that the mixture of fish oil and soybean oil balanced the
w6:w3 PUFA ratio (2:1) and improved colonic inflamma-
tion. The diet enriched with fish oil (F group) presented
intermediate effects, probably because of the imbalance
in the w-6:w-3 PUFA ratio (1:6). Several studies demon-
strated the importance of modulating the w-6:w-3 ratio
to obtain beneficial effects rather than simply reducing
w-6 PUFA levels [21]. The imbalance in the w-6:w-3 ratio,
as is observed in western diets (10:1), may be related to an
increased production of proinflammatory cytokines and
eicosanoids in autoimmune diseases and IBDs [22]. Fish
oil contains large amounts of SAFA, which has been asso-
ciated with chronic diseases [23,24]. Several studies indi-
cate that the optimal w-6:w-3 ratio may vary according to
the disease; however, the ratio between 5-2:1 has been
associated with decreased inflammation in patients with
IBD, rheumatoid arthritis and other inflammatory dis-
eases and with reduced rectal cell proliferation in patients
with colorectal cancer [25].
It has been suggested that patients with IBD show
changes in the metabolism of long chain polyunsaturated
fatty acids (LCPUFAS). These fatty acids are well known
to be parts of the cell membrane and precursors of
important eicosanoids, which participate in inflamma-
tory response. Alterations in the availibility of certain
LCPUFAS can exert influence on the inflammatory and
anti-inflammatory eicosanoids production [12] and may
be relevant in maintaining the chronic inflammatory
activity in the colon [26].
Fish oil supplementation may be able to down-regulate
the expressions of some genes, which have been involved
in UC [12,27].
In this paper, we evaluated animals in the recuperation
phase, 5 days after stopping DSS exposure. We decided to
evaluate this period for considering diet as a complemen-
tary therapy; in a severe inflammation model, the benefit
effects would be more difficult to observe. The protocol
was started using DSS 5% in drinking water for 7 days,
and later, it was decreased to 2% for 10 days, when the
animals were sacrificed [21]. However, the mortality in
this experimental model was 80%, and so we decided to
decrease the DSS to 3% for 7 days and water for 5 days.
This high mortality could be associated with different
molecular weight of DSS and/or the animals' gender. The
mol wt of 36,000 - 50,000 for DSS and Wistar female rats
were not used in this paper.
As expected, all animals presented rectal bleeding char-
acterizing the colitis symptoms. It was observed that this
bleeding was intensified in the F group, being associated
with the higher elevated DAI found. The high w-3 intake
in the F group (shown in Table 2), as compared to C and
FS group, could be associated with a decreased produc-
tion of thromboxanes A2, a potent platelet aggregator, as
it has been demonstrated with fish oil rich-diets
[23,25,28]. The DAI evaluation showed lower values in
the SF group suggesting that the balance of fish and soy-
bean oils exerts protective effects in decreasing disease
activity and protecting against weight loss. These are
important factors considering that deficit in the nutri-
tional status occurs in patients with IBD during the dis-
ease activity and that dietary fatty acids interventions
Figure 2 Histology (hematoxylin-eosin, magnification, × 200) of 
colonic samples taken from Wistar rats receiving 3% DSS for 7 
days and water for 5 days. (A) Control group, fed control diet, 
showed ulceration of epithelial superficies (black arrow), intense in-
flammatory cellular infiltration (white arrow) and destruction of colonic 
architecture; (B) Fish group, fed fish diet, showed basal lamina edema 
and moderate cellular infiltrate (arrow); (C) Soybean/Fish group, fed 
soybean/fish diet showed light cellular infiltrate (arrow). The soybean/
fish diet was more efficient than the fish diet in attenuating morpho-
logic damage and preserving colonic architecture.
Table 4: Colon length (cm), inflammation score and corticosterone concentration (μg/100 mL) in DSS-induced colitis rats 
fed control, fish or soybean/fish diet.
Colon length Inflammation Score Corticosterone
Control 14.26 ± 0.24 2.33 ± 0.33 14.57 ± 1.40
Fish 16.85 ± 0.30* 1.83 ± 0.30 14.63 ± 1.11
Soybean/Fish 17.21 ± 0.28* 1.16 ± 0.16* 16.17 ± 0.89
Values represent means ± SEM, n = 6; * Different (p < 0.05) from Control group.
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status [29].
In this paper, increased IL-10 levels in the SF and F
groups could be associated with a protective effect of
diets on weight loss, colon length and DNA damage,
important inflammatory factors in IBD. Cytokines play a
key role in the development, recurrence and exacerbation
of the inflammatory process in IBD. IL-10 is an immuno-
regulatory cytokine that influences the immunological
system, both on the innate and cell-mediated response. It
affects the gastrointestinal mucosal homeostasis through
the down-regulation of colon inflammation and the inhi-
bition of both antigen presentation and release of pro-
inflammatory cytokines, and it is related to the activity of
regulatory cells [30,31].
No difference was found in INF-y and IL-4 cytokines.
Evaluating cytokine release in experimental colitis, Diele-
man et al. [32] also found no increase in IL-4 and INF-γ
in the acute phase of UC. These authors observed these
elevated cytokines only in later phases (14 days after DSS
stopping).
An increase in the colonic MPO activity, a specific
marker of polymorphonuclear neutrophils activity, was
used as a measure of the inflammatory status [33]. The
present study showed that the MPO activity decreased
only in the SF group in relation to the C group, which
matched the lower inflammation based on the inflamma-
tory score and decreased DNA damage. Once more, the
balanced w6:w3 ratio used in the SF group shows a bene-
ficial effect on UC. In fact, neutrophils may mediate a
mucosal injury by the synthesis and release of ROS [6],
and it has been known that oxidative stress is a patho-
genic factor correlated with DNA damage [9].
There was a clear correlation between increased IL-10
levels and decreased DNA damage, and to the best of our
knowledge, this is the first demonstration of a causal
association between these variables associated with IBD.
It is likely that the anti-inflammatory effects from IL-10
attenuating mucosal inflammation are associated with
putative protection in DNA.
Considering that inflammation can accelerate tumori-
genesis in the colon, and anti-inflammatory drugs have
been used to prevent this event, a dietary intervention
with a mixture of fish and soybean oil may be an effective
complementary therapy to prevent cancer. Also, it could
be an alternative to the use of anti-inflammatory drugs
and their associated side effects.
Some studies have concluded that there are some bene-
fits of fish oil in IBD [34-36] However, a recent study
reported no effect of w-3 PUFA on disease activity in
humans IBD [37]. These controversial results have been
attributed to the different w-3 PUFA doses used [28].
Here, the mixture of fish and soybean oil in the diet was
demonstrated to be better than the use of fish oil as an
exclusive source of fat.
Our laboratory has demonstrated that a diet rich in fish
or soybean oil could exert beneficial effects on the acute
inflammation model. This effect was partially attributed
to the elevated basal corticosterone levels induced by
these diets [38,39]. Here, we show that plasma corticos-
terone levels did not differ in the three experimental
groups. This strongly suggests that the anti-inflammatory
effects obtained by dietary treatment using fish or soy-
bean/fish diet could not be attributed to the action of this
hormone.
In conclusion, the main beneficial effects exerted by the
balance between fish and soybean oil were in reduced dis-
Table 5: IL-4, IL-10 and INF-y concentrations (ρg/mL), MPO activity (U/mg) in the colon and DNA damage levels (tail 
moment/100 cells isolated from colon) of DSS-induced colitis rats fed Control, Fish or Soybean/Fish diet.
IL-4 IL-10 INF-y MPO DNA damage
Control 209.36 ± 47.30 310.01 ± 33.36 206.08 ± 37.27 0.84 ± 0.23 4.66 ± 0.16
Fish 255.66 ± 37.25 539.79 ± 57.14* 234.81 ± 21.04 0.60 ± 0.09 3.46 ± 0.11*
Soybean/Fish 272.64 ± 44.22 653.50 ± 61.69* 285.15 ± 43.35 0.21 ± 0.06* 2.94 ± 0.19*
Values represent means ± SEM, n = 6 rats; * Different (p < 0.05) from Control group.
Figure 3 Correlation between DNA damage levels (tail moment/
100 cells isolated from colon) and tissue IL-10 concentration (ρg/
mL) in all DSS-induced colitis rats.
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Page 8 of 9ease activity, improved histological score, increased IL-10
cytokine, decreased MPO and protection against DNA
damage. The inverse correlation between IL-10 levels and
DNA damage also demonstrated that the w-6:w-3 ratio
(2:1) was important in reducing disease activity and colon
cancer prevention associated with colitis.
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